HDFC Nifty500 Multicap 50.25.25 Index Fund vs NIPPON INDIA PHARMA FUND

Portfolio Overlap Analysis · HDFC vs Nippon

5.3%
Low Overlap
28 common stocks · Rank #27743 of 28,292 pairs
Fund B
NIPPON INDIA PHARMA FUND
Nippon · Sectoral - Pharma

Common Holdings (10)

StockWt% in HDFC Nifty500 Multicap 50.25.2Wt% in NIPPON INDIA PHARMAOverlap
Sun Pharmaceutical Industries Limited
Pharmaceuticals & Biotechnology
13.08%0.67%0.67%
Lupin Limited
Pharmaceuticals & Biotechnology
7.99%0.37%0.37%
Fortis Healthcare Limited
Healthcare Services
1.25%0.33%0.33%
Divi's Laboratories Limited
Pharmaceuticals & Biotechnology
6.56%0.30%0.30%
Apollo Hospitals Enterprise Limited
Healthcare Services
5.17%0.29%0.29%
Max Healthcare Institute Limited
Healthcare Services
3.49%0.29%0.29%
Dr. Reddy's Laboratories Limited
Pharmaceuticals & Biotechnology
5.81%0.28%0.28%
Cipla Limited
Pharmaceuticals & Biotechnology
5.67%0.27%0.27%
Aurobindo Pharma Limited
Pharmaceuticals & Biotechnology
2.50%0.23%0.23%
Alkem Laboratories Limited
Pharmaceuticals & Biotechnology
2.20%0.22%0.22%

Unique to HDFC Nifty500 Multicap 50.25.2

  • HDFC Bank Ltd.4.92%
  • ICICI Bank Ltd.3.57%
  • Reliance Industries Ltd.3.41%
  • Bharti Airtel Ltd.1.90%
  • Larsen and Toubro Ltd.1.82%
  • State Bank of India1.81%
  • Infosys Limited1.65%
  • Axis Bank Ltd.1.44%
  • Kotak Mahindra Bank Limited1.11%
  • Mahindra & Mahindra Ltd.1.10%

Unique to NIPPON INDIA PHARMA

  • MedPlus Health Services Limited3.70%
  • Vijaya Diagnostic Centre Limited3.49%
  • Ajanta Pharma Limited3.41%

Sector Overlap Breakdown

Pharmaceuticals & Biotechnology
4.0% (21)
Healthcare Services
1.3% (7)

Analysis

AI-generated comparative analysis coming soon.

More comparisons for HDFC Nifty500 Multicap 50.25.2

More comparisons for NIPPON INDIA PHARMA

Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.